antviral/dental caries

BACKGROUND OF THE INVENTION Field of the Invention This invention relates to antiseptic compositions and, more particularly, to a nasal antiseptic barrier composition having antimicrobial, antiviral, and antifungal properties. Discussion of the Related Art In recent years, outbreaks of new and

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to antiseptic compositions and, more particularly, to a nasal antiseptic barrier composition having antimicrobial, antiviral, and antifungal properties. 2. Discussion of the Related Art In recent years, outbreaks of new and

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to antiseptic compositions and, more particularly, to a nasal antiseptic barrier composition having antimicrobial, antiviral, and antifungal properties. 2. Discussion of the Related Art In recent years, outbreaks of new and

BACKGROUND OF THE INVENTION Field of the Invention This invention relates to antiseptic compositions and, more particularly, to a nasal antiseptic barrier composition having antimicrobial, antiviral, and antifungal properties. Discussion of the Related Art In recent years, outbreaks of new and

FIELD OF INVENTION This invention relates to a general method for reducing the duration of common colds and reducing the severity of common cold symptoms by applying medicament to the oral cavity rather than by applying medicament to the nose, by injection or by oral ingestion. More particularly,

BACKGROUND Uterine cervical cancer is a public health problem worldwide, primarily affecting women in emerging countries, Mexico included. German scientist Harald zur Hausen, awarded the Nobel Prize for Medicine in 2008, discovered the major role that the human papillomavirus has in the development

BACKGROUND OF THE INVENTION Targeting the early phase of HIV-1 infection, including virus entry, as a prophylactic modality is a focus of intense research. HIV-1 entry involves a series of events that include attachment to the host cell and fusion of the viral and target cell membranes. HIV-1 entry

FIELD OF THE INVENTION This invention is directed to an in situ-formed bioactive tissue adherent compliant film produced by spraying a methyl acetate solution of an absorbable crystallizable polymer containing at least one soluble or microdispersed bioactive agent. Depending on the application site,

CROSS-REFERENCE TO RELATED APPLICATION The present application claims priority to provisional application U.S. Ser. No. 61/337,295, filed Feb. 2, 2010. FIELD OF THE INVENTION This invention is directed to an in situ-formed bioactive tissue adherent compliant film produced by spraying a methyl

FIELD OF THE INVENTION This invention is directed to an in situ film-forming methyl acetate-based solution of an absorbable segmented block copolymer with amorphous and semi-crystalline segments containing at least one soluble or microdispersed bioactive agent. Depending on the application site, the

FIELD OF THE INVENTION This invention deals with fiber-reinforced composite systems comprising an absorbable fiber and a partially or essentially non-absorbable matrix for use in the controlled release of one or more bioactive agent(s) at the desired biological site, which may entail intravaginal,

FIELD OF THE INVENTION This invention deals with fiber-reinforced composite systems comprising an absorbable fiber and a partially or essentially non-absorbable matrix for use in the controlled release of one or more bioactive agent(s) at the desired biological site, which may entail intravaginal,

FIELD OF THE INVENTION This invention deals with fiber-reinforced composite systems comprising an absorbable fiber and a partially or essentially non-absorbable matrix for use in the controlled release of one or more bioactive agent(s) at the desired biological site, which may entail intravaginal,

BACKGROUND OF THE INVENTION Microglia are the resident macrophages of the brain and retina. They become activated in diseases such as diabetes and retinal degeneration where cells die, causing microglia to phagocytose cellular debris. Activation of retinal microglia occurs in a mouse model of

FIELD OF THE INVENTION This invention deals with a fiber-reinforced composite ring system for the controlled release of one or more bioactive agent(s) at the desired biological sites, which may entail intravaginal, intraperitoneal, and subcutaneous administration of such agent(s). The composite ring